Accountability and Generating Evidence for Global Health: Misoprostol in Nepal

Postpartum haemorrhage (PPH) is a major cause of maternal morbidity and mortality in Nepal.

Abstract

Postpartum haemorrhage (PPH) is a major cause of maternal morbidity and mortality in Nepal. Compounded by the remote terrain, endemic poverty, and a lack of access to health facilities, the use of misoprostol has advantages over the standard use of oxytocin for PPH management. Drawing on a qualitative study of a pilot intervention managed by the Nepal Family Health Programme, the authors map the institutional relationships involved in the design, implementation, and practices for bringing misoprostol into national policy. In the intense and competitive global and national policy arena, sustained lobbying and getting the ‘right people’ on board were as powerful drivers as the quality of the intervention itself.

The case study takes us to the heart of the debate around the politics of generation of evidence for interventions in global health programmes, and ultimately the question of accountability for health policy and practice.

This work is part of ‘New Norms and Forms of Development: Brokerage in Maternal and Child Health Service Development and Delivery in Nepal and Malawi’ project supported by the Economic and Social Research Council (ESRC) and the UK Department for International Development.

Citation

Raj Sharma Jeevan, Rekha Khatri, Ian Harper (2018) Accountability and Generating Evidence for Global Health: Misoprostol in Nepal. IDS Bulletin Volume 49 Issue 2 http://dx.doi.org/10.19088/1968-2018.135

Accountability and Generating Evidence for Global Health: Misoprostol in Nepal

Updates to this page

Published 8 May 2018